Downstream Processing
-
Thermo Fisher Scientific Bio-Expo Live 2024: Downstream Bioprocessing
8/15/2024
Review downstream process tools from Thermo Fisher Scientific to enable optimal biologics purification, including chromatography resins, chemicals, process liquids, and buffers.
-
Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective
2/18/2025
Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.
-
An All-In-One Solution For Residual DNA Quantitation
5/22/2025
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
Key Attributes To Monitor During Cell Line Development Of Complex Proteins
9/13/2024
In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, panelists discuss key attributes to monitor during cell line development processes.
-
Three Novel Protein Therapeutic Worldviews
9/13/2024
In this segment of the Bioprocess Online Live event Early Process Considerations For Novel Protein Therapeutics, we meet panelists who share their topline perspectives on developing complex, novel protein therapeutics.
-
Upstream To Downstream: A Comprehensive Approach To AAV Production
12/7/2023
How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.
-
Process Intensification Development Challenges At AZ and AbbVie
8/27/2024
In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, panelists respond to audience questions about the challenges they’ve encountered while developing process intensification strategies.
-
What Bioprocessing Bottlenecks Does Process Intensification Address?
8/27/2024
Supply chains, consumables, and data are identified as three of the management challenges that intensified processes and process automation technology (PAT) are addressing at AbbVie and AstraZeneca.
-
Why AstraZeneca and AbbVie Are Intensifying Processes
8/27/2024
In this segment of the Bioprocess Online Live event Bioprocess Intensification In The Real World, our speakers share the motivation for continued process intensification in their respective organizations.
-
Bioprocessing Equipment And Automation Product Portfolio Overview
5/19/2025
Accelerate biotherapeutic development with innovative bioprocessing equipment and automation solutions that feature single-use mixers, bioreactors, and more to streamline workflows and speed products to market.